Compound library / Cognitive / Nootropic
Benzylpiperazino-aminopyridine compound originally developed by Neuralstem that promotes hippocampal neurogenesis in vitro; explored for depression and cognitive enhancement. Phase 2 trials for MDD showed mixed results.
| Category | Cognitive / Nootropic |
|---|---|
| Typical route | Oral |
| Half-life | Not well characterized in humans |
| Common dose range | 40-80 mg/day in published trials |
| Typical cycle length | 8-12 weeks |
BioHack Track models NSI-189 (Phosphate) at a half-life of 4 hours, so every dose you log is decayed against that curve and the app shows what is still circulating — not just what you typed.
Typically supplied as capsules or powder; no reconstitution needed.
Store at room temperature, away from light.
Not FDA-approved. Phase 2 data was mixed; not a proven antidepressant. Long-term effects on hippocampal growth in humans are not established.
Track NSI-189 (Phosphate) in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.
These open a search of each database for NSI-189 (Phosphate) — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
General reference compiled for use inside the app, not medical advice and not a recommendation to take anything. Dose ranges are what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.